Matches in Wikidata for { <http://www.wikidata.org/entity/Q66029839> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66029839 description "clinical trial" @default.
- Q66029839 description "ensayu clínicu" @default.
- Q66029839 description "klinisch onderzoek" @default.
- Q66029839 description "клінічне випробування" @default.
- Q66029839 name "ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Tradema" @default.
- Q66029839 name "ADVAIR® DISKUS® Inhaler" @default.
- Q66029839 type Item @default.
- Q66029839 label "ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Tradema" @default.
- Q66029839 label "ADVAIR® DISKUS® Inhaler" @default.
- Q66029839 prefLabel "ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Tradema" @default.
- Q66029839 prefLabel "ADVAIR® DISKUS® Inhaler" @default.
- Q66029839 P1132 Q66029839-1CD6850D-7D4E-4446-A5E2-AD92A233AECF @default.
- Q66029839 P1476 Q66029839-383BE839-549D-4021-A987-31E3EABE1D25 @default.
- Q66029839 P17 Q66029839-158249B7-25AE-4531-B5B1-C42E964F094B @default.
- Q66029839 P17 Q66029839-C1C3511B-DF88-4784-8217-907E2ECBC4B5 @default.
- Q66029839 P2899 Q66029839-E77AD1ED-FCFD-498E-AE49-10B462721004 @default.
- Q66029839 P3098 Q66029839-719D00AA-9BA9-421B-8C65-17D433A5A5E6 @default.
- Q66029839 P31 Q66029839-E8DF5AAF-7355-4E80-8C6B-D805F8DAF06B @default.
- Q66029839 P4844 Q66029839-A8685A5D-DE1B-41BA-B2B9-B4FE6512DFC9 @default.
- Q66029839 P580 Q66029839-FE5AF68D-6D54-4B50-8868-79FF0AB2189D @default.
- Q66029839 P582 Q66029839-4EB51691-18E5-4565-9B2C-B0A4447FB71B @default.
- Q66029839 P6099 Q66029839-77B16C18-C7C7-448C-BD9E-29358D7964DD @default.
- Q66029839 P6153 Q66029839-A598CA82-63C7-4897-AC47-1C2CB3513856 @default.
- Q66029839 P8363 Q66029839-17EAD833-7D19-45F1-9F98-7D65119AE41A @default.
- Q66029839 P859 Q66029839-44652D50-9D3D-47C9-9E72-49B27C8FFF71 @default.
- Q66029839 P921 Q66029839-016B4303-7155-4614-B6C2-5827B8A9ABFD @default.
- Q66029839 P921 Q66029839-B01E07C3-BAAD-4AE2-90E6-7F84EC0092A7 @default.
- Q66029839 P1132 "+740" @default.
- Q66029839 P1476 "A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol DISKUS® Inhaler Combination Product 250/50mcg Twice Daily With Salmeterol DISKUS® Inhaler 50mcg Twice Daily on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q66029839 P17 Q16 @default.
- Q66029839 P17 Q30 @default.
- Q66029839 P2899 "+40" @default.
- Q66029839 P3098 "NCT00144911" @default.
- Q66029839 P31 Q30612 @default.
- Q66029839 P4844 Q27264747 @default.
- Q66029839 P580 "2004-10-01T00:00:00Z" @default.
- Q66029839 P582 "2006-12-01T00:00:00Z" @default.
- Q66029839 P6099 Q42825046 @default.
- Q66029839 P6153 Q212322 @default.
- Q66029839 P8363 Q78089383 @default.
- Q66029839 P859 Q212322 @default.
- Q66029839 P921 Q199804 @default.
- Q66029839 P921 Q54038755 @default.